Polymorphism of human cytochrome P-450

References

• Al-Dabbagh S. G., Idle J. R., Smith R. L. Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in inbred rat strains. Journal of Pharmacy and Pharmacology 1981; 33: 161–164
   PubMed Web of Science ®Google Scholar
• Alwine J. C., Kemp D. J., Stark G. R. Method for detection of specific mRNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proceedings of the National Academy of Sciences USA 1977; 74: 5350–5354
   PubMed Web of Science ®Google Scholar
• Ayesh R. R., Idle J. R., Ritchie J. C., Crothers M. J., Hetzell M. R. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer. Nature 1984; 312: 169–170
   PubMed Web of Science ®Google Scholar
• Barbeau A., Roy M., Paris S., Clouther T., Plasse L., Poirier J. Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine. Lancet 1985; 2: 1213–1215
   PubMed Web of Science ®Google Scholar
• Boobis A. R., Davies D. S. Human cytochromes P-450. Xenobiotica 1984; 14: 151–185
   PubMed Web of Science ®Google Scholar
• Cartwright R. A., Philip R. A., Rogers H. J., Glashan R. W. Genetically determined debrisoquine oxidation capacity in bladder cancer. Carcinogenesis 1985; 5: 1191–1192
   Google Scholar
• Chirgwin J. M., Przybylia A. E., Macdonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Distlerath L. M., Guengerich F. P. Characterization of a human liver cytochrome P-450 involved in the oxidation of debrisoquine and other drugs by using antibodies raised to the analogous rat enzyme. Proceedings of the National Academy of Sciences USA 1984; 81: 7348–7352
   PubMed Web of Science ®Google Scholar
• Distlerath L. M., Guengerich F. P. Enzymology of human liver cytochromes P-450. Mammalian Cytochromes P-450, F. P. Guengerich, 1986, in the press
   Google Scholar
• Distlerath L. M., Reilly P. E. B., Martin M. V., Davis G. G., Wilkinson G. R., Guengerich F. P. Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry 1985; 260: 9057–9067
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Liebler D. C. Enzymatic activation of chemicals to toxic metabolites. CRC Critical Reviews in Toxicology 1985; 14: 259–307
   Web of Science ®Google Scholar
• Guengerich F. P., Martin M. V., Beaune P. H., Kremers P., Wolff T., Waxman D. J. Characterization of the rat and human microsome cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in drug oxidation. Journal of Biological Chemistry 1986; 261: 5051–5060
   PubMed Web of Science ®Google Scholar
• Idle J. R., Mahgoub A., Sloan T. P., Smith R. L., Mbanefo C. O., Bababunmi E. A. Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Letters 1981; 11: 331–338
   PubMed Web of Science ®Google Scholar
• Kleinbloesem C. H., Van Brummeln P., Faber H., Danhof M., Vermeulen N. P. E., Bremmer D. D. Variability in nifedipine kinetics and dynamics: a new oxidation polymorphism in man. Biochemical Pharmacology 1984; 33: 3721–3724
   PubMed Web of Science ®Google Scholar
• Küpfer A., Preisig R. Inherited defects of hepatic drug metabolism. Seminars in Liver Disease 1983; 3: 341–354
   PubMed Web of Science ®Google Scholar
• Larrey D., Distlerath L. M., Dannan G. A., Wilkinson G. R., Guengerich F. P. Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolism. Biochemistry 1984; 23: 2787–2795
   PubMed Web of Science ®Google Scholar
• Mahgoub A., Idle J. R., Dring I. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of debrisoquine in man. Lancet 1977; 2: 584–586
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular Cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1982
   Google Scholar
• Picket C. B., Jeter R. L., Wang R., Lu A. Y. H. Coordination induction of multiple mRNAs specific for rat liver phenobarbital-inducible cytochromes P-450. Archives of Biochemistry and Biophysics 1983; 225: 854–860
   PubMedGoogle Scholar
• Sanger R. S., Nicklen S., Coulson A. R. DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academcy of Sciences USA 1977; 74: 5463–5467
   PubMedGoogle Scholar
• Scott J., Poffenbarger P. C. Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 1979; 28: 41–51
   PubMed Web of Science ®Google Scholar
• Shimada T., Misono K., Guengerich F. P. Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism: purification and characterization of two similar forms involved in the reaction. Journal of Biological Chemistry 1986; 261: 909–921
   PubMed Web of Science ®Google Scholar
• Wang P. P., Beaune P., Kaminsky L. S., Dannan G. A., Kadlubar F. F., Larrey D., Guengerich F. P. Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 1983; 22: 5375–5385
   PubMed Web of Science ®Google Scholar
• Wang P., Mason P. S., Guengerich F. P. Purification of human liver cytochrome P-450 and comparison to the enzyme isolated from rat liver. Archives of Biochemistry and Biophysics 1980; 199: 206–219
   PubMed Web of Science ®Google Scholar
• Wedlund P. J., Aslanian M. D., Mcallister C. B., Wilkinson G. R., Branch R. A. Mephenytoin hydroxylation in caucasians: frequency of a new oxidative drug metabolism polymorphism. Clinical Pharmacology and Therapeutics 1984; 36: 773–780
   PubMed Web of Science ®Google Scholar
• Wislocki P. G., Miwa G. T., Lu A. Y. H. Reactions catalyzed by the cytochrome P-450 system. Enzymatic Basis of Detoxication, W. B. Jakoby. Academic Press, New York 1980; vol. 1: 135–182
   Google Scholar
• Wolff T., Distlerath L. M., Worthington M. T., Groopman J. D., Hammons G. J., Kadlubar F. F., Prough R. A., Martin M. V., Guengerich F. P. Substrate specificity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Research 1985; 45: 2116–2122
   PubMed Web of Science ®Google Scholar
• Young R. A., Davis R. W. Efficient isolation of genes by using antibody probes. Proceedings of the National Academy of Sciences USA 1983; 80: 1194–1198
   PubMed Web of Science ®Google Scholar